Although CDKN2A normally negatively regulates CDK4, there was significantly higher CDK4 mRNA expression in CDKN2Ahigh meningiomas compared to CDKN2Alow cases across all cohorts (Supplementary Fig. 5a-d). This evidence concerns the gene CDKN2A and meningioma.